Komori
Revision of earnings forecasts6678Techno Medica Co.,Ltd.Electrical Equipment and Precision Instruments

Notice Regarding Revisions to Earnings Forecasts for the Second Quarter (Interim Period) of the Fiscal Year Ending March 2027

The earnings forecast for the cumulative second quarter of the fiscal year ending March 2027 has been revised upward. Although the increase in net sales is modest, operating income, ordinary income and interim net income have been raised significantly.

Worth reading
55In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
83.3
%
Wording
Conditional
How definitive the wording is.

Revised forecast

Fiscal year ending March 2027 · Cumulative second-quarter periodPrevious forecast published 11 May 2026
Net Sales4,270→4,360million
+2.1%
Operating profit170→300million
+76.5%
Ordinary income170→310million
+82.4%
Profit attributable to owners of the parent120→220million
+83.3%
Net income per share17.4→31.9yen and sen
+83.3%

The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.

Reason for the revision

Increased sales of consumables and other products in Japan and overseas are expected, and selling, general and administrative expenses declined because research and development expenses were incurred later than initially expected. These effects are not expected to affect full-year results.

Previous-period resultsNet sales: ¥4,104 million; operating income: ¥266 million; ordinary income: ¥294 million; interim net income: ¥203 million; interim net income per share: ¥29.31
Dividend forecast revisionThere is no revision to the dividend forecast accompanying this revision to the earnings forecast.
Revised forecast
ItemDetails
Net Sales¥4,270 million → ¥4,360 million(+2.1%)
Operating profit¥170 million → ¥300 million(+76.5%)
Ordinary income¥170 million → ¥310 million(+82.4%)
Profit attributable to owners of the parent¥120 million → ¥220 million(+83.3%)
Net income per share17.40 yen and sen → 31.90 yen and sen
Fiscal Period CoveredFiscal year ending March 2027
Period CoveredCumulative second-quarter period
Publication date of previous forecast11 May 2026
Previous-period resultsNet sales: ¥4,104 million; operating income: ¥266 million; ordinary income: ¥294 million; interim net income: ¥203 million; interim net income per share: ¥29.31
Reason for the revisionIncreased sales of consumables and other products in Japan and overseas are expected, and selling, general and administrative expenses declined because research and development expenses were incurred later than initially expected. These effects are not expected to affect full-year results.
Dividend forecast revisionThere is no revision to the dividend forecast accompanying this revision to the earnings forecast.
Items this document does not state (2)
Details and amount of extraordinary lossConsolidated / non-consolidated

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

In addition to expected increases in sales of consumables and other products in Japan and overseas, selling, general and administrative expenses declined because research and development expenses were incurred later than initially expected. These effects are not expected to affect full-year results.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Revisions to Earnings Forecasts for the Second Quarter (Interim Period) of the Fiscal Year Ending March 2027 | Techno Medica Co.,Ltd. (6678) timely disclosure | Komori